advertisement
Hitzl W 51
Showing records 1 to 25 | Display all abstracts from Hitzl W105844 Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions
Kluckner M
Medicina (Kaunas, Lithuania) 2022; 58:
106773 Diagnostic and prognostic value of the Laboratory Risk Indicator for Necrotising Fasciitis (LRINEC) based on an 18 years' experience
Breidung D
Journal of Plastic, Reconstructive and Aesthetic Surgery 2023; 77: 228-235
106420 Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery
Feige J
Neurology international 2022; 14: 943-951
105948 Time Is Fascia: Laboratory and Anamnestic Risk Indicators for Necrotizing Fasciitis
Breidung D
Surgical infections 2022; 23: 747-753
105765 Patient-Reported Outcome Analysis after Resident Performed Upper Blepharoplasty: A Suitable Procedure for Young Surgeons
Mahrhofer M
Facial plastic surgery : FPS 2023; 39: 98-103
106474 Five-year follow-up of corneal endothelial cell density after transscleral ab interno glaucoma gel stent implantation
Lenzhofer M
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 1073-1082
106420 Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery
Berek K
Neurology international 2022; 14: 943-951
105765 Patient-Reported Outcome Analysis after Resident Performed Upper Blepharoplasty: A Suitable Procedure for Young Surgeons
Schwaiger K
Facial plastic surgery : FPS 2023; 39: 98-103
106474 Five-year follow-up of corneal endothelial cell density after transscleral ab interno glaucoma gel stent implantation
Motaabbed A
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 1073-1082
105844 Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions
Nierlich P
Medicina (Kaunas, Lithuania) 2022; 58:
106773 Diagnostic and prognostic value of the Laboratory Risk Indicator for Necrotising Fasciitis (LRINEC) based on an 18 years' experience
Malsagova AT
Journal of Plastic, Reconstructive and Aesthetic Surgery 2023; 77: 228-235
105948 Time Is Fascia: Laboratory and Anamnestic Risk Indicators for Necrotizing Fasciitis
Grieb G
Surgical infections 2022; 23: 747-753
106420 Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery
Seiberl M
Neurology international 2022; 14: 943-951
105844 Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions
Hitzl W
Medicina (Kaunas, Lithuania) 2022; 58:
105948 Time Is Fascia: Laboratory and Anamnestic Risk Indicators for Necrotizing Fasciitis
Malsagova AT
Surgical infections 2022; 23: 747-753
105765 Patient-Reported Outcome Analysis after Resident Performed Upper Blepharoplasty: A Suitable Procedure for Young Surgeons
Weitgasser L
Facial plastic surgery : FPS 2023; 39: 98-103
106474 Five-year follow-up of corneal endothelial cell density after transscleral ab interno glaucoma gel stent implantation
Colvin HP
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 1073-1082
106773 Diagnostic and prognostic value of the Laboratory Risk Indicator for Necrotising Fasciitis (LRINEC) based on an 18 years' experience
Barth AA
Journal of Plastic, Reconstructive and Aesthetic Surgery 2023; 77: 228-235
105844 Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions
Aschacher T
Medicina (Kaunas, Lithuania) 2022; 58:
106474 Five-year follow-up of corneal endothelial cell density after transscleral ab interno glaucoma gel stent implantation
Hohensinn M
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 1073-1082
105765 Patient-Reported Outcome Analysis after Resident Performed Upper Blepharoplasty: A Suitable Procedure for Young Surgeons
Schoeller T
Facial plastic surgery : FPS 2023; 39: 98-103
106773 Diagnostic and prognostic value of the Laboratory Risk Indicator for Necrotising Fasciitis (LRINEC) based on an 18 years' experience
Megas IF
Journal of Plastic, Reconstructive and Aesthetic Surgery 2023; 77: 228-235
106420 Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery
Hilpold P
Neurology international 2022; 14: 943-951
105948 Time Is Fascia: Laboratory and Anamnestic Risk Indicators for Necrotizing Fasciitis
Barth AA
Surgical infections 2022; 23: 747-753
106474 Five-year follow-up of corneal endothelial cell density after transscleral ab interno glaucoma gel stent implantation
Steiner V
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 1073-1082
